Michael E. Severino
2016
In 2016, Michael E. Severino earned a total compensation of $7.2M as Executive Vice President, Research & Development and Chief Scientific Officer at AbbVie, a 10% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $375,080 |
|---|---|
| Non-Equity Incentive Plan | $1,596,000 |
| Option Awards | $850,908 |
| Salary | $960,969 |
| Stock Awards | $3,359,376 |
| Other | $101,530 |
| Total | $7,243,863 |
Severino received $3.4M in stock awards, accounting for 46% of the total pay in 2016.
Severino also received $375.1K of change in pension value and nonqualified deferred compensation earnings, $1.6M in non-equity incentive plan, $850.9K in option awards, $961K in salary and $101.5K in other compensation.
Rankings
In 2016, Michael E. Severino's compensation ranked 883rd out of 14,075 executives tracked by ExecPay. In other words, Severino earned more than 93.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 883 out of 14,075 | 94th |
Division Manufacturing | 287 out of 5,488 | 95th |
Major group Chemicals And Allied Products | 75 out of 1,900 | 96th |
Industry group Drugs | 48 out of 1,543 | 97th |
Industry Pharmaceutical Preparations | 40 out of 1,173 | 97th |
Source: SEC filing on March 19, 2018.
Severino's colleagues
We found four more compensation records of executives who worked with Michael E. Severino at AbbVie in 2016.